US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Invesco Dorsey Wright Healthcare Momentum ETF

58.76

+1.392.43%

Post-market: 58.800.0430+0.07%19:30 EDT

Volume:17.38K

Turnover:1.02M

Market Cap:284.38M

PE:19.22

High:59.14

Open:57.66

Low:57.66

Close:57.37

52wk High:64.10

52wk Low:44.47

Shares:4.84M

Float Shares:4.84M

Volume Ratio:0.51

T/O Rate:0.36%

Dividend:1.53

Dividend Rate:2.60%

EPS(TTM):3.06

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Sector Update: Healthcare

MT Newswires Live

Update: US Equity Futures Slightly Lower Pre-Bell as Traders Await Developments in US-Iran Talks

MT Newswires Live

Roivant Sciences price target raised to $41 from $37.50 at BofA

Immunovant Falls After Lupus Drug Setback

Roivant Says IMVT-1402 Cutaneous Lupus Study Misses Primary Endpoint, Halts Development in CLE

Roivant Sciences - Imvt-1402 Demonstrates Favorable Safety and Tolerability Profile

THOMSON REUTERS

Roivant Announces Topline Results from Proof-of-Concept Study of Imvt-1402 in Cutaneous Lupus Erythematosus

THOMSON REUTERS

Roivant Sciences - All Other Clinical Development Timelines Remain on Track

THOMSON REUTERS

Axsome Therapeutics, Inc. : Truist Securities Assumes Coverage with Buy Rating; Target Price $285 vs $200

THOMSON REUTERS

Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000

Lucid Diagnostics advances Medicare reimbursement and coding infrastructure

AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib

Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015

Shinva Medical Subsidiary Secures Class III Medical Device Approvals

Axsome Presents Alzheimer’s Agitation Caregiver Survey Results at Psych Congress 2026

China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund

Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks

Axsome's Auvelity Launch Shows Early Strength in Alzheimer's Agitation, RBC Says

MT Newswires Live

Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products

Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.tigrgood.cn/stock/PTH/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"PTH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","market":"US","secType":"STK","nameCN":"Invesco Dorsey Wright Healthcare Momentum ETF","latestPrice":58.757,"timestamp":1791576000000,"preClose":57.3658,"halted":0,"volume":17383,"hourTrading":{"tag":"盘后","latestPrice":58.8,"preClose":58.757,"latestTime":"19:30 EDT","volume":6,"amount":352.2346,"timestamp":1791588604239,"change":0.043,"changeRate":0.000732,"amplitude":0},"delay":0,"changeRate":0.024251383228334613,"floatShares":4840000,"shares":4840000,"eps":3.057033,"marketStatus":"Market Closed","change":1.3912,"latestTime":"10-09 16:00:00 EDT","open":57.66,"high":59.1447,"low":57.66,"amount":1021175.720865,"amplitude":0.025881,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":3.057033,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791792000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":57.3658,"sharesOutstanding":2480000,"nav":57.33757,"aum":287288216.63,"dividendRate":0.02597,"bidAskSpread":0.001697,"preHourTrading":{"tag":"盘前","latestPrice":57.37,"preClose":57.3658,"latestTime":"07:00 EDT","volume":1,"amount":57.37,"timestamp":1791543606921,"change":0.0042,"changeRate":0.000073,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":58.8,"preClose":58.757,"latestTime":"19:30 EDT","volume":6,"amount":352.2346,"timestamp":1791588604239,"change":0.043,"changeRate":0.000732,"amplitude":0},"volumeRatio":0.5106189207267566,"impliedVol":0.2074,"impliedVolPercentile":0.9442},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"PTH\",,,,,undefined,":{"symbol":"PTH","floatShares":4840000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5106189207267566,"shares":4840000,"dividePrice":1.5259,"high":59.1447,"amplitude":0.025881,"preClose":57.3658,"low":57.66,"week52Low":44.47,"pbRate":"--","week52High":64.1,"institutionHeld":0,"latestPrice":58.757,"eps":3.057033,"divideRate":0.02597,"volume":17383,"delay":0,"ttmEps":3.057033,"open":57.66,"prevYearClose":49.701,"prevWeekClose":60.2082,"prevMonthClose":60.76,"prevQuarterClose":60.76,"fiveDayClose":60.2082,"twentyDayClose":60.7692,"sixtyDayClose":58.2191},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/PTH\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"PTH","amount":1.52645,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-26","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-26"},{"date":"2024-06-24","symbol":"PTH","amount":0.02545,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-06-24","defaultRemindTime":1719235800000,"name":"Invesco Dorsey Wright Healthcare Momentum ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-06-28","payableDate":"2024-06-24","currency":"USD","dateTimestamp":1719201600000,"payDate":"2024-06-28"},{"market":"US","date":"2023-07-17","symbol":"PTH","defaultRemindTime":1689600600000,"type":"split","dateTimestamp":1689566400000,"forFactor":1,"toFactor":3,"ratio":0.3333333333333333}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"PTH\",market:\"US\",,,undefined,":[{"executeDate":"2024-06-24","recordDate":"2024-06-24","paymentDate":"2024-06-28","value":0.02545,"currency":"USD"},{"executeDate":"2025-12-22","recordDate":"2025-12-22","paymentDate":"2025-12-26","value":1.52645,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"PTH\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"PTH\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2669486413","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2669486413","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669486413?lang=en_us&edition=fundamental","pubTime":"2026-09-23 21:00","pubTimestamp":1790168425,"startTime":"0","endTime":"0","summary":"Healthcare stocks were steady premarket Wednesday, with the State Street Health Care Select Sector SPDR ETF  slightly declining and the iShares Biotechnology ETF  inactive.Roivant Sciences  said its Immunovant  subsidiary plans to stop development of IMVT-1402 in cutaneous lupus erythematosus after a proof-of-concept study failed to achieve statistical significance on the primary endpoint. Shares of Immunovant and Roivant were down 6.1% and 1%, respectively, pre-bell.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IMVT","IBB","XBI","XLV","LU0029874061.USD","ROIV","BK4139","LU0128526141.USD","PTH","BK4588","HCSG","BK4581","BK4007","BK4137","BK4585","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669372486","title":"Update: US Equity Futures Slightly Lower Pre-Bell as Traders Await Developments in US-Iran Talks","url":"https://stock-news.laohu8.com/highlight/detail?id=2669372486","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669372486?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:48","pubTimestamp":1790167737,"startTime":"0","endTime":"0","summary":"(Updates with economic data, recent oil price movements, world markets' overview, and corporate stock movements.)US equity futures were slightly lower pre-bell Wednesday as traders awaited development","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1670628061.USD","BK4517","BK4139","BK4585","CARX","IONL","BK4168","BK4113","BK4588","IONZ","LU1366192091.USD","IOYY","RCL","WQTM","BK4142","COAL","BK4602","LU0266013472.USD","BK4141","CART","IMVT","IONQ","BK4591","BHP","QTUP","BK4566","WNDR","ROIV","SLX","BK4170","LU0300736062.USD","LU1670627923.USD","BK4007","PTH","IONX","LU0300736492.USD","IONC","CQTM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669048537","title":"Roivant Sciences price target raised to $41 from $37.50 at BofA","url":"https://stock-news.laohu8.com/highlight/detail?id=2669048537","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669048537?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:15","pubTimestamp":1790165711,"startTime":"0","endTime":"0","summary":"BofA analyst Chi Fong raised the firm’s price target on Roivant Sciences (ROIV) to $41 from $37.50 and keeps a Neutral rating on the shares after h...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-41-from-37-50-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/roivant-sciences-price-target-raised-to-41-from-37-50-at-bofa-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PTH","ROIV","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669483473","title":"Immunovant Falls After Lupus Drug Setback","url":"https://stock-news.laohu8.com/highlight/detail?id=2669483473","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669483473?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:04","pubTimestamp":1790165052,"startTime":"0","endTime":"0","summary":"BUZZ-Immunovant falls after lupus drug setback** Shares of biotech firm ImmunovantIMVT.Ofall 4.5% to $35.6 premarket** Stock set to open at its lowest level in over three months, if losses hold** Co p","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nL6N45F0L8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","PTH","BK4585","IMVT","ROIV","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669269100","title":"Roivant Says IMVT-1402 Cutaneous Lupus Study Misses Primary Endpoint, Halts Development in CLE","url":"https://stock-news.laohu8.com/highlight/detail?id=2669269100","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669269100?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:05","pubTimestamp":1790161507,"startTime":"0","endTime":"0","summary":"Roivant says IMVT-1402 cutaneous lupus study misses primary endpoint, halts development in CLERoivant reported topline results from a proof-of-concept study of IMVT-1402 in cutaneous lupus erythematos","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nNDL5xYLBJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BCDF","IE00BN0W2V16.EUR","IE00BQXX3D17.EUR","BK4007","IE00BN0W2T93.GBP","LU0314104364.USD","SG9999014005.SGD","BK4588","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014039.USD","IE00BKPKM429.USD","BK4585","LU2095319765.USD","ROIV","PTH","BK4112","BK4139","IE00B64PRP62.GBP","IE00BN0W2W23.USD","SG9999014013.SGD","IE00BQXX3C00.GBP","IE00B3QW5Z07.USD","NDAQ","IE00BQXX3F31.USD","LU2210149790.SGD","LU2210150020.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669676100","title":"Roivant Sciences - Imvt-1402 Demonstrates Favorable Safety and Tolerability Profile","url":"https://stock-news.laohu8.com/highlight/detail?id=2669676100","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669676100?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161201,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JH70M:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","BK4139","BK4007","ROIV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669100988","title":"Roivant Announces Topline Results from Proof-of-Concept Study of Imvt-1402 in Cutaneous Lupus Erythematosus","url":"https://stock-news.laohu8.com/highlight/detail?id=2669100988","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669100988?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JH70M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PTH","ROIV","BK4007","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669006461","title":"Roivant Sciences - All Other Clinical Development Timelines Remain on Track","url":"https://stock-news.laohu8.com/highlight/detail?id=2669006461","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669006461?lang=en_us&edition=fundamental","pubTime":"2026-09-23 19:00","pubTimestamp":1790161201,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nTUA6JH70M:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","ROIV","PTH","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669310159","title":"Axsome Therapeutics, Inc. : Truist Securities Assumes Coverage with Buy Rating; Target Price $285 vs $200","url":"https://stock-news.laohu8.com/highlight/detail?id=2669310159","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669310159?lang=en_us&edition=fundamental","pubTime":"2026-09-23 17:03","pubTimestamp":1790154221,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260923:nFWN45F0EI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2324357040.USD","BK4585","BK4007","AXSM","PTH","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669120310","title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","url":"https://stock-news.laohu8.com/highlight/detail?id=2669120310","media":"Reuters","labels":["shareholding","insiderTrades"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669120310?lang=en_us&edition=fundamental","pubTime":"2026-09-23 06:00","pubTimestamp":1790114446,"startTime":"0","endTime":"0","summary":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini disposes of common shares worth $347,000Revolution Medicines Chief Global Commercialization Officer Anthony Mancini sold 1,7","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260922:nNDL64Mcy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Revolution Medicines Chief Global Commercialization Officer Anthony Mancini Disposes of Common Shares Worth $347,000","news_tag":"shareholding,insiderTrades","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B2B36J28.USD","LU0109394709.USD","CANC","BBH","BK4139","IDNA","IE0009355771.USD","IE00BJJMRZ35.SGD","IE00BFTCPJ56.SGD","LU0889565916.HKD","PTH","IE00B4R5TH58.HKD","LU0320765992.SGD","IE0009354923.USD","RVMD","IE00BJT1NW94.SGD","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669147769","title":"Lucid Diagnostics advances Medicare reimbursement and coding infrastructure","url":"https://stock-news.laohu8.com/highlight/detail?id=2669147769","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669147769?lang=en_us&edition=fundamental","pubTime":"2026-09-22 21:29","pubTimestamp":1790083753,"startTime":"0","endTime":"0","summary":"Lucid Diagnostics ( ($LUCD) ) has provided an update. On September 22, 2026, Lucid Diagnostics announced key advances in payment, billing and codin...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/lucid-diagnostics-advances-medicare-reimbursement-and-coding-infrastructure?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MHIP","RXD","HCA","TMED","LU1150488135.SGD","JHMH","XLVX","PSCH","BK4551","LU0433182093.SGD","RSPH","SG9999014039.USD","LU1267930490.SGD","PINK","LCIZ","IE00B3S45H60.SGD","BK4099","LNGR","LUCD","REZ","PTH","DVXV","HTEC","IEHS","LU0868494617.USD","XHE","BK4588","LCDL","MHIG","FHLC","LU1084165304.USD","XLVI","IHF","BMED","LU0310800379.SGD","IHI","SG9999014013.SGD","BK4082","TRUH","LU0310799852.SGD","IYH","FXH","MEDI","AGNG","LU0708994859.HKD","IE00B775SV38.USD","LCID","CURE","BK4585","LU0203347892.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669142210","title":"AIM ImmunoTech Highlights Ampligen’s Potential Role in the Evolving Pancreatic Cancer Treatment Landscape Following FDA Approval of Revolution Medicines’ Daraxonrasib","url":"https://stock-news.laohu8.com/highlight/detail?id=2669142210","media":"GlobeNewswire","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669142210?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:55","pubTimestamp":1790081700,"startTime":"0","endTime":"0","summary":"Daraxonrasib is an important therapeutic advance, but pancreatic cancer is not a simple disease where one successful targeted drug makes additional therapeutic development unnecessary. We believe Ampligen has the potential to complement and extend therapies such as daraxonrasib by helping to overcome the immune biological barriers that have h","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366375/29489/en/aim-immunotech-highlights-ampligen-s-potential-role-in-the-evolving-pancreatic-cancer-treatment-landscape-following-fda-approval-of-revolution-medicines-daraxonrasib.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IDNA","BK4585","RVMD","IE00BJT1NW94.SGD","BK4588","IE00B2B36J28.USD","IE00B4R5TH58.HKD","IE00BFTCPJ56.SGD","IE0002141913.USD","IE0009355771.USD","PTH","BBH","LU0889565916.HKD","LABU","LU0109394709.USD","LU0320765992.SGD","CANC","BK4139","IE00BJJMRZ35.SGD","IE0009354923.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669144047","title":"Propanc Biopharma Highlights Differentiated PRP Pancreatic Cancer Data Versus Emerging Pan-RAS Program ERAS-0015","url":"https://stock-news.laohu8.com/highlight/detail?id=2669144047","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669144047?lang=en_us&edition=fundamental","pubTime":"2026-09-22 20:30","pubTimestamp":1790080200,"startTime":"0","endTime":"0","summary":"New Preclinical PDAC Package for PRP Shows >90% Tumor-Growth Inhibition & >2.5-Fold Survival Benefit; Company Contrasts Mechanism, Breadth, & Development Role Against Erasca’s Phase 1 ERAS-0015 Datase","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/09/22/3366329/0/en/propanc-biopharma-highlights-differentiated-prp-pancreatic-cancer-data-versus-emerging-pan-ras-program-eras-0015.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2357305700.SGD","LU0109394709.USD","LU1548497426.USD","LU1023057109.AUD","BBH","IE00B12V2V27.USD","IE00BYQNZ168.SGD","BK4141","LU1854104046.USD","BK4139","LU1861219969.SGD","BK4108","SG9999011746.SGD","RVMD","BK4588","ONX","LU2360107325.USD","IE0002141913.USD","LU0509642566.USD","LU0320765992.SGD","BK4585","PTH","LU2298322129.HKD","LU1861220033.SGD","LU1720051017.SGD","IE0009354923.USD","BK4605","BK4548","LU1854103824.USD","BK4512","ON","PPCB","LU0269904917.USD","BK4565","IE00BYTNYN87.SGD","01698","TME","LU0359202008.SGD","BK4509","BK4531","IE00BFTCPJ56.SGD","ERAS","PDX","ONG","BK4535","IDNA","IE00BJT1NW94.SGD","LU0724618433.USD","CANC","BK4571"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1107418547","title":"Shinva Medical Subsidiary Secures Class III Medical Device Approvals","url":"https://stock-news.laohu8.com/highlight/detail?id=1107418547","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1107418547?lang=en_us&edition=fundamental","pubTime":"2026-09-22 15:40","pubTimestamp":1790062838,"startTime":"0","endTime":"0","summary":"Shinva Medical Instrument Co., Ltd. (600587.SH) has announced that its subsidiary, Shinva Surgical Instruments Co., Ltd., recently received the Medical Device Registration Certificates issued by...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RSPH","BK0188","LNGR","LGHT","BK1100","MEDX","MDEV","HART","09996","BK1574","600587","PTH","GDOC","BK1583","159883","IEIH","BK0251","BK0028","AGNG"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669150647","title":"Axsome Presents Alzheimer’s Agitation Caregiver Survey Results at Psych Congress 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2669150647","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669150647?lang=en_us&edition=fundamental","pubTime":"2026-09-21 19:01","pubTimestamp":1789988488,"startTime":"0","endTime":"0","summary":"Axsome presents Alzheimer’s agitation caregiver survey results at Psych Congress 2026Axsome highlighted caregiver survey results at Psych Congress 2026 in New Orleans on Sept. 17-18, 2026.Polling of 7","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260921:nNDL5lLRbf:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014005.SGD","SG9999014039.USD","BK4112","IE00BKPKM429.USD","AXSM","SG9999014021.USD","LU2210150020.SGD","SG9999014013.SGD","IE00B3QW5Z07.USD","BCDF","BK4505","PTH","IE00BN0W2V16.EUR","IE00BGHQF748.EUR","IE00BQXX3F31.USD","IE00BQXX3C00.GBP","BK4007","LU0314104364.USD","BK4585","IE00BN0W2T93.GBP","IE00BQXX3D17.EUR","NDAQ","IE00BN0W2W23.USD","IE00B64PRP62.GBP","BK4588","LU2324357040.USD","LU2210149790.SGD","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1126968451","title":"China-Singapore Suzhou Industrial Park Invests Up to RMB 20 Million in Medical Device and Biotech Fund","url":"https://stock-news.laohu8.com/highlight/detail?id=1126968451","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1126968451?lang=en_us&edition=fundamental","pubTime":"2026-09-21 16:34","pubTimestamp":1789979675,"startTime":"0","endTime":"0","summary":"China-Singapore Suzhou Industrial Park Development Group Co., Ltd. (601512.SH) has announced its plan to participate as a limited partner in the Anhui Daotong Yaohui Equity Investment Partnership...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HELX","MEDX","HART","RSPH","BK1100","601512","LGHT","AGNG","PTH","GDOC","BK1583","MDEV","LNGR","WDNA","09996","BK1574","BK0273","159883","IEIH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112501840","title":"Citi Highlights Policy Boost for Innovative Drugs and Medical Devices, Names Key Sector Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=1112501840","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1112501840?lang=en_us&edition=fundamental","pubTime":"2026-09-21 15:17","pubTimestamp":1789975044,"startTime":"0","endTime":"0","summary":"Citi has issued a research report following the joint release of the 15th Five-Year Plan for the Pharmaceutical Industry Development by the Ministry of Industry and Information Technology and other...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["06978","BK1521","IE0008368742.USD","IE00B543WZ88.USD","BK4559","LU0029874905.USD","AGNG","LU0320765646.SGD","159992","LU1226287875.USD","LU0880133367.SGD","IBBQ","BK1141","LU0980610538.SGD","LU1688375341.USD","LU1152091754.HKD","LU1144417596.USD","LU1813983027.USD","LU1267930227.SGD","BK1100","IE00BZ08YT58.USD","LU0196878994.USD","LU0149534421.HKD","LU0244354667.USD","BK1576","LU0819121731.USD","LU0823426308.USD","LU0315179316.USD","LU2125154778.USD","LU2097828557.USD","LU2543165471.USD","LU0572944931.SGD","LU0098860793.USD","LU1831875114.USD","BK4504","LU1244550577.SGD","BK1161","IYF","LU0588546209.SGD","LU0029874061.USD","LU1242518857.USD","BK1583","LU1791807156.HKD","LU0162691827.USD","LU0516423091.SGD","LU0359202008.SGD","LU0516422366.SGD","LU1226287529.USD","SG9999002463.SGD","LU2125154935.USD","LU0314109678.HKD","LU1226288253.USD","LU1201861249.SGD","LU1242518931.SGD","LU1668664300.SGD","LU0359201885.HKD","LU0823426480.USD","LU0856984785.SGD","LU1807302812.USD","LU1226287792.SGD","LU1794554557.SGD","LU0417516902.SGD","BK1589","LU0648001328.SGD","LGHT","LU0181495838.USD","SG9999002562.SGD","HK0000165453.HKD","IEIH","IE00B5MMRT66.SGD","LU0320764599.SGD","LU0051755006.USD","LU0128522744.USD","LU0326950275.SGD","PTH","FTXO","MEDX","BK1610","IE00B0JY6N72.USD","GDOC","LU1188198961.HKD","01093","LU2039709279.SGD","LU0456846285.SGD","09996","BK4566","LU0708995153.HKD","LU0067412154.USD","LU2462157665.USD","LU1152091168.USD","LU0348825331.USD","LU0348827113.USD","C","LU0348735423.USD","LU0516422952.EUR","LU1366192091.USD","LU0170899867.USD","LU0203347892.USD","LU1023057109.AUD","LU0540923850.HKD","06990","LU0140636845.USD","LU0320764243.SGD","LU0501845795.SGD","LU2097828805.USD","LU2242644610.SGD","LU1244550221.USD","BK1191","IE00BZ08YS42.EUR","LU0039217434.USD","LU1951186391.HKD","SG9999004220.SGD","LNGR","LU0203345920.USD","HART","02269","LU1506573853.SGD","LU2097828474.EUR","LU1162221912.USD","TFNS","BK4588","LU0502904849.HKD","LU1720050803.USD","LU2488822045.USD","LU0417516738.SGD","LU0708995583.HKD","KURE","LU1244550494.USD","LU2360032135.SGD","LU2456880835.USD","LU0516422440.USD","LU1960683339.HKD","LU1993786604.SGD","BK4585","LU0455707207.USD","BK1574","LU0043850808.USD","LU0128526141.USD","LU0607220059.USD","BK4534","LU1226288170.HKD","159883","LU2097828631.EUR","LU0477156953.USD","BK1515","LU0359201612.USD","LU0130102774.USD","LU0072913022.USD","LU0128525689.USD","LU0456827905.SGD","LU1880383366.USD","LU2236285917.USD","RSPH","01276","LU1969619763.USD","LU2097828714.EUR","IE00BSNM7G36.USD","LU3063872942.SGD","01801","LU2328871848.SGD","LU0463099449.HKD","03347","LU2417539215.USD","LU0052756011.USD","BK4207","LU0072461881.USD","LU0634319403.HKD","LU0979878070.USD","IE00BZ08YR35.GBP","IE00B031HY20.USD","LU1008478684.HKD","LU1074936037.SGD","LU1328277881.USD","LU0561508036.HKD","LU0106831901.USD","LU0307460666.USD","LU0314106906.USD","MDEV","IE0008369823.USD","LU0516423174.USD","LU0052750758.USD","LU0310800965.SGD","LU0130517989.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668869922","title":"Axsome's Auvelity Launch Shows Early Strength in Alzheimer's Agitation, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2668869922","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668869922?lang=en_us&edition=fundamental","pubTime":"2026-09-18 23:38","pubTimestamp":1789745882,"startTime":"0","endTime":"0","summary":"Axsome Therapeutics'  investors remain focused on the launch of Auvelity for Alzheimer's agitation, RBC Capital Markets said Friday in a report.Early signs from the launch are encouraging, and Auvelity is on track to meet RBC's $804 million fiscal 2026 sales estimate and exceed Wall Street expectations, the 26-page report said.RBC's survey of 77 physicians, representing about 2,600 patients, found doctors like Auvelity's profile, expect to increase use, and are seeing steady patient growth.Physicians estimated that about one-third of their Alzheimer's agitation patients also have depression, which often leads doctors to start patients on Auvelity's full dose rather than the starter pack, a pattern that helps lift paid prescriptions and revenue, the report said.RBC maintained its outperform rating on Axsome and its $297 price target.Price: 210.42, Change: -3.86, Percent Change: -1.80","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","LU2324357040.USD","BK4585","PTH","AXSM","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1157650345","title":"Tellgen Corporation's Subsidiaries Obtain Regulatory Approvals for Two Diagnostic Products","url":"https://stock-news.laohu8.com/highlight/detail?id=1157650345","media":"Stock News","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157650345?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:58","pubTimestamp":1789732702,"startTime":"0","endTime":"0","summary":"Tellgen Corporation (300642.SZ) has officially announced that its controlling subsidiaries, Jiangxi Tellgen Life Science Technology Co., Ltd. and Shanghai Maishi Biotechnology Co., Ltd., have...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IEIH","PTH","GDOC","BK1100","RSPH","BK0046","159883","09996","BK1583","HART","MDEV","MEDX","LGHT","300642","LNGR","BK1574","AGNG","BK0042","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2668492827","title":"Analysts Offer Insights on Healthcare Companies: Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN) and Axsome Therapeutics (AXSM)","url":"https://stock-news.laohu8.com/highlight/detail?id=2668492827","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2668492827?lang=en_us&edition=fundamental","pubTime":"2026-09-18 19:30","pubTimestamp":1789731047,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Eli Lilly & Co (LLY), BioMarin Pharmaceutical (BMRN)...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-biomarin-pharmaceutical-bmrn-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-eli-lilly-co-lly-biomarin-pharmaceutical-bmrn-and-axsome-therapeutics-axsm-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE00BFSS7M15.SGD","LU2361044949.HKD","LU2271345857.HKD","IE0004445239.USD","LU2896262040.SGD","BK4566","LU1280957306.USD","SG9999013999.USD","LU0820561909.HKD","ELIL","IE00BN29S564.USD","IE00BFTCPJ56.SGD","LLYZ","IE0002141913.USD","TMED","MEDX","IE00B7SZLL34.SGD","LU0096364046.USD","LU2087625088.SGD","CURE","LU0345770308.USD","SG9999001176.SGD","LU2552382215.SGD","LU0210536198.USD","LU2602419157.SGD","IE00BJJMRY28.SGD","IHE","LU0417517546.SGD","IE00B7KXQ091.USD","LU0354030511.USD","LU0097036916.USD","FTXH","LU1720051108.HKD","LU0158827948.USD","GDOC","MHIP","IYH","FHLC","LU0456855351.SGD","LU0882574139.USD","VHT","LU1720051017.SGD","BK4534","LU1917777945.USD","LU0943347566.SGD","LU2237443978.SGD","LU2237443465.HKD","LU2552382132.HKD","SG9999018857.SGD","IE00BJT1NW94.SGD","LU0174119429.USD","LU2112291526.USD","BK4599","LU1988902786.USD","LU0094547139.USD","LU2023250330.USD","HRTS","LU2468319806.SGD","LU2168564065.EUR","LU0787776722.HKD","LU0882574055.USD","LU1023059063.AUD","LU1061106388.HKD","LU2361045086.USD","PTH","LU0109391861.USD","LU2168563687.JPY","LU0006306889.USD","LU2211815571.USD","SG9999015986.USD","LU1232071149.USD","LU0353189680.USD","LU0471298777.SGD","LU2089284900.SGD","SG9999014914.USD","IE00BJLML261.HKD","LU0203201768.USD","LLII","LU0385154629.USD","IE0004445015.USD","LU1623119135.USD","LU2023251221.USD","LU2417539215.USD","GB00BDT5M118.USD","LU0345770993.USD","LU0708995401.HKD","IE00B19Z3581.USD","LU0466842654.USD","BK4139","BK4533","LU2023250504.SGD","LU0689472784.USD","IE00B2B36J28.USD","IE0005OL40V9.USD","SG9999015945.SGD","LU0079474960.USD","IE00B1BXHZ80.USD","LU1814569148.SGD","LU2491050071.SGD","BK4007","LU2237443895.HKD","IE00B1XK9C88.USD","SG9999014906.USD","LU2360106947.USD","AGNG","LU2361044865.SGD","SG9999015952.SGD","LU1323610961.USD","LU2491049909.HKD","LLYX","LU1064131342.USD","LU0316494557.USD","LU2108987350.USD","LU2471134879.HKD","LU0158827781.USD","LU0256863902.USD","IE00BK4W5M84.HKD","LU0109394709.USD","BK4505","LU0061475181.USD","LU0820561818.USD","IE00B775H168.HKD","LU0114720955.EUR","LU2756315318.SGD","BK4588","IE00BK4W5L77.USD","LU0823434740.USD","IE0001KFT4U8.USD","LU0323591593.USD","LU1035775433.USD","LU1989771016.USD","LU2324357040.USD","LU2168564495.EUR","LU0823416689.USD","LU2471134952.CNY","LU2491050154.USD","LU0823434583.USD","LU1093756168.USD","LU1267930730.SGD","LU1551013425.SGD","LU2265009873.SGD","LU2264538146.SGD","IE00BJJMRZ35.SGD","LU0203202063.USD","LU2168564222.USD","BMRN","LU2756315664.SGD","LU2552382058.USD","IE00BJJMRX11.SGD","LU2111349929.HKD","RXL","LU2089984988.USD","AXSM","SGXZ51526630.SGD","LU0889565916.HKD","LU1127390331.HKD","LU0320765992.SGD","SGXZ99366536.SGD","SG9999017495.SGD","LU0471298694.HKD","SG9999014880.SGD","LU0432979614.USD","LU2237443549.SGD","LU1069344957.HKD","LU0353189763.USD","LLY","LU1974910355.USD","IE00B19Z3B42.SGD","SGXZ81514606.USD","LU1629891620.HKD","SG9999015978.USD","LU1551013342.USD","LU2750360641.GBP","LU0234572021.USD","LU1868837136.USD","LU0266013472.USD","ELIS","BK4516","LU1979441026.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","LU2746668461.USD","LU0225283273.USD","LU2461242641.AUD","THNR","LU1057294990.SGD","LU2746668974.SGD","SGXZ57979304.SGD","LU0964807845.USD","IE00B4JS1V06.HKD","LU0058720904.USD","LU2063271972.USD","LU2028103732.USD","LU2750360997.AUD","LU2462591350.SGD","BK4585","IE0002270589.USD","LU0122379950.USD","PPH","CANC","LU0786609619.USD","LU2237443622.USD","JDOC","LU2471134523.USD","LU1691799644.USD","LU2237443382.USD","LU0256863811.USD","LU2168564149.EUR","TRUH","LU0672654240.SGD","LU1548497426.USD","SGXZ31699556.SGD","LU1868836757.USD","LU1712237335.SGD","LU0683600562.USD","LU2213496289.HKD","IE00BKDWB100.SGD","LU1868837300.USD","BK4581","ILDR","LU0320765059.SGD","PJP","LU2471134796.USD","LU0133085943.USD","LU0289739699.SGD","LU2462157665.USD","MEDI","SG9999018865.SGD","LU0820562030.AUD","LU2106854487.HKD","LU1145028129.USD","SG9999014898.SGD","LU0238689110.USD","LU2357305700.SGD","IE00BKPKM429.USD","IE00BWXC8680.SGD","LU2089283258.USD","LU1093756325.SGD","LU2236285917.USD","SG9999001176.USD","LU1983299246.USD","IE00BFSS8Q28.SGD","LU1868836591.USD","WDNA","LU1291159041.SGD","LU1868836914.USD","LU2237438978.USD","OZEM","LU0198837287.USD","LU0640476718.USD","IE0009355771.USD","IXJ","LU2456880835.USD","LU0354030438.USD","LU0106261372.USD","LU1366192091.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}